About Us

Abcodia is a clinical stage company engaged in the development of novel tests for the early detection of cancer. The Company’s first product is the ROCA® Test for the early detection of ovarian cancer.

Abcodia’s products are based on expertise in measuring and modelling dynamic changes over time of clinical variables including test results from serum-based markers before cancer is clinically diagnosed.

Abcodia is a privately held company funded through investments from Albion Ventures, Cambridge Innovation Capital, Scottish Equity Partners and UCL Business. The company is headquartered in U.K.

Testing blood samples for pancreatic cancer biomarkers.
Abcodia Hero

Our Mission

Abcodia’s mission is to improve cancer survival rates through early detection.

Our Values

At Abcodia, we value:

  • Patient safety above all else
  • Innovation to find ways to detect cancer earlier
  • Collaboration with partners to carry out our mission